The salt tolerance of rice (Oryza sativa) correlates with the ability to exclude Na 1 from the shoot and to maintain a low cellular Na 1 /K 1 ratio. We have identified a rice plasma membrane Na 1 /H 1 exchanger that, on the basis of genetic and biochemical criteria, is the functional homolog of the Arabidopsis (Arabidopsis thaliana) salt overly sensitive 1 (SOS1) protein. The rice transporter, denoted by OsSOS1, demonstrated a capacity for Na 1 /H 1 exchange in plasma membrane vesicles of yeast (Saccharomyces cerevisiae) cells and reduced their net cellular Na 1 content. The Arabidopsis protein kinase complex SOS2/ SOS3, which positively controls the activity of AtSOS1, phosphorylated OsSOS1 and stimulated its activity in vivo and in vitro. Moreover, OsSOS1 suppressed the salt sensitivity of a sos1-1 mutant of Arabidopsis. These results represent the first molecular and biochemical characterization of a Na 1 efflux protein from monocots. Putative rice homologs of the Arabidopsis protein kinase SOS2 and its Ca 21 -dependent activator SOS3 were identified also. OsCIPK24 and OsCBL4 acted coordinately to activate OsSOS1 in yeast cells and they could be exchanged with their Arabidopsis counterpart to form heterologous protein kinase modules that activated both OsSOS1 and AtSOS1 and suppressed the salt sensitivity of sos2 and sos3 mutants of Arabidopsis. These results demonstrate that the SOS salt tolerance pathway operates in cereals and evidences a high degree of structural conservation among the SOS proteins from dicots and monocots.Rice (Oryza sativa) is one of the most important cereal crops in tropical and temperate regions of the world. Among all common environmental stresses, salinity is a major factor decreasing the yield in rice cultivation in coastal areas and in irrigated farmlands. Problems associated with salinity are water deficit imposed by the greater osmolarity of the soil solution and the cellular damage inflicted by excessive ion accumulation in plant tissues. Comparison of rice subspecies and varieties differing in tolerance to salinity has shown that greater tolerance correlates with the ability to exclude Na 1 from the shoot and maintain a low Na 1 /K1 ratio (Golldack et al., 2003;Lee et al., 2003;Ren et al., 2005). For instance, the salt-sensitive variety IR29 accumulated Na 1 in leaves at 5-to 10-fold greater concentrations than the salt-tolerant lines BK or Pokkali (Golldack et al., 2003). In contrast, shoot K 1 concentration per se showed no relation to salinity tolerance in japonica spp. and only weak correlation in indica spp. varieties (Golldack et al., 2003;Lee et al., 2003). Because steady accumulation of Na 1 is what injures the cells of leaves at moderate salinity levels (Flowers et al., 1991;Munns, 1993), restricting the translocation of Na 1 is a mechanism for salt tolerance that plays a major role in rice (Lee et al., 2003;Ren et al., 2005). The gene SKC1/HKT8, responsible for a major quantitative trait locus imparting a high K 1 / Na 1 balance in shoots and salt tolerance, encodes...
The plasma membrane sodium/proton exchanger Salt-OverlySensitive 1 (SOS1) is a critical salt tolerance determinant in plants. The SOS2-SOS3 calcium-dependent protein kinase complex upregulates SOS1 activity, but the mechanistic details of this crucial event remain unresolved. Here we show that SOS1 is maintained in a resting state by a C-terminal auto-inhibitory domain that is the target of SOS2-SOS3. The auto-inhibitory domain interacts intramolecularly with an adjacent domain of SOS1 that is essential for activity. SOS1 is relieved from auto-inhibition upon phosphorylation of the auto-inhibitory domain by SOS2-SOS3. Mutation of the SOS2 phosphorylation and recognition site impeded the activation of SOS1 in vivo and in vitro. Additional amino acid residues critically important for SOS1 activity and regulation were identified in a genetic screen for hypermorphic alleles.ion transport | salinity | sodium tolerance S alinity is a major problem in agriculture because the total area of salt-affected soils, including saline and sodic soils, exceeds 900 million ha (1). Salt-affected soils reduce both the ability of crops to take up water and the availability of mineral nutrients. Often, the high sodium (Na) content relative to other cations is the main factor affecting plant growth by causing a set of metabolic derangements (2). Because most crop species have only very limited capacities to cope with excess Na, the elucidation of Na tolerance mechanisms in plants is of paramount importance (2). Plant ion transporters mediating Na fluxes have recently been cloned and characterized, and the knowledge of the regulatory mechanisms of transporter abundance and activity in response to environmental, hormonal, and developmental signals is critical for understanding salinity tolerance (3). The plasma membrane Na/H antiporter SOS1 is essential for the salt tolerance of various model plants, including Arabidopsis thaliana (4) and its halophytic relative Thellungiella salsuginea (5), tomato (6), and the moss Physcomitrella patens (7). SOS1 is thought to mediate Na efflux at the root epidermis and longdistance transport from roots to shoots (4, 6) while protecting individual cells from Na toxicity (7-9). SOS1 is also indirectly required for the uptake of potassium (K) in the presence of Na, although the mechanistic basis is not fully understood (7,8,10). Both the protein kinase SOS2 and its associated calcium-sensor subunit SOS3 are required for the posttranslational activation of SOS1 Na/H exchange activity in Arabidopsis (11,12), and a similar regulatory module operates also in cereals (13).To understand further the mechanism(s) of SOS1 regulation, we identified the SOS2-dependent phosphorylation site and began to dissect the structure-function relationship in the SOS1 protein.Our results indicate that the SOS1 C-terminal domain comprises an auto-inhibitory domain the activity of which is counteracted by SOS2-dependent phosphorylation upon salinity stress. Results SOS1 ResiduesPhosphorylated by the SOS2 Protein Kinase. We have ...
Blindness due to corneal diseases is a common pathology affecting up to 23 million individuals worldwide. The tissue-engineered anterior human cornea, which is currently being tested in a Phase I/II clinical trial to treat severe corneal trophic ulcers with preliminary good feasibility and safety results. This bioartificial cornea is based on a nanostructured fibrin-agarose biomaterial containing human allogeneic stromal keratocytes and cornea epithelial cells, mimicking the human native anterior cornea
Preventing influenza infection early after transplantation is essential, given the disease's high mortality. A multicentre prospective cohort study in adult solid organ transplant recipients (SOTR) receiving the influenza vaccine during four consecutive influenza seasons (2009-2013) was performed to assess the immunogenicity and safety of influenza vaccination in SOTR before and 6 months after transplantation. A total of 798 SOTR, 130 of them vaccinated within 6 months of transplantation and 668 of them vaccinated more than 6 months since transplantation. Seroprotection was similar in both groups: 73.1% vs. 76.5% for A/(H1N1)pdm (p 0.49), 67.5% vs. 74.1% for A/H3N2 (p 0.17) and 84.2% vs. 85.2% for influenza B (p 0.80), respectively. Geometric mean titres after vaccination did not differ among groups: 117.32 (95% confidence interval (CI) 81.52, 168.83) vs. 87.43 (95% CI 72.87, 104.91) for A/(H1N1)pdm, 120.45 (95% CI 82.17, 176.57) vs. 97.86 (95% CI 81.34, 117.44) for A/H3N2 and 143.32 (95% CI 103.46, 198.53) vs. 145.54 (95% CI 122.35, 174.24) for influenza B, respectively. After adjusting for confounding factors, time since transplantation was not associated with response to vaccination. No cases of rejection or severe adverse events were detected in patients vaccinated within the first 6 months after transplantation. In conclusion, influenza vaccination within the first 6 months after transplantation is as safe and immunogenic as vaccination thereafter. Thus, administration of the influenza vaccine can be recommended as soon as 1 month after transplantation.
The presence of the cyclic nucleotides 3',5'-cyclic adenyl monophosphate (cAMP) and 3',5'-cyclic guanyl monophosphate (cGMP) in plants is now generally accepted. In addition, cAMP and cGMP have been implicated in the regulation of important plant processes such as stomatal functioning, monovalent and divalent cation fluxes, chloroplast development, gibberellic acid signalling, pathogen response and gene transcription. However, very little is known regarding the components of cyclic nucleotide signalling in plants. In this addendum, the evidence for specific mechanisms of plant cyclic nucleotide signalling is evaluated and discussed.
IntroductionThere is a need to find alternatives to the use of human donor corneas in transplants because of the limited availability of donor organs, the incidence of graft complications, as well as the inability to successfully perform corneal transplant in patients presenting limbal deficiency, neo-vascularized or thin corneas, etc. We have designed a clinical trial to test a nanostructured fibrin-agarose corneal substitute combining allogeneic cells that mimics the anterior human native cornea in terms of optical, mechanical and biological behaviour.Methods and analysisThis is a phase I-II, randomised, controlled, open-label clinical trial, currently ongoing in ten Spanish hospitals, to evaluate the safety and feasibility, as well as clinical efficacy evidence, of this bioengineered human corneal substitute in adults with severe trophic corneal ulcers refractory to conventional treatment, or with sequelae of previous ulcers. In the initial phase of the trial (n=5), patients were sequentially recruited, with a safety period of 45 days, receiving the bioengineered corneal graft. In the second phase of the trial (currently ongoing), subjects are block randomised (2:1) to receive either the corneal graft (n=10), or amniotic membrane (n=5), as the control treatment. Adverse events, implant status, infection signs and induced neovascularization are evaluated as determinants of safety and feasibility of the bioengineered graft (main outcomes). Study endpoints are measured along a follow-up period of 24 months, including 27 post-implant assessment visits according to a decreasing frequency. Intention to treat, and per protocol, and safety analysis will be performed.Ethics and disseminationThe trial protocol received written approval by the corresponding Ethics Committee and the Spanish Regulatory Authority and is currently recruiting subjects. On completion of the trial, manuscripts with the results of phases I and II of the study will be published in a peer-reviewed journal.Trial registrationCT.gov identifier: NCT01765244 (Jan2013). EudraCT number: 2010-024290-40 (Dec2012).
Background Alzheimer disease (AD) is a progressive neurodegenerative disorder affecting the elderly with a prevalence of 7.1% in women and 3.3% in men. Sex-related patterns have been reported in prognosis, biomarker status, and risk factors. Despite this, the interaction of sex has received limited attention, with AD trials persistently recruiting lower numbers of women than the population distribution and a lack of information on the sex-disaggregated effects of anti-dementia therapies. This is the first study aiming to identify the role of sex in the selection for screening in AD clinical trials. Methods This cross-sectional study provides a comprehensive analysis of screening eligibility according to a set of pre-selection criteria currently applied at Fundació ACE memory clinic for a more efficient trial screening process. A cohort of 6667 women and 2926 men diagnosed with AD dementia (55%) or mild cognitive impairment (45%) was analyzed. We also assessed the frequencies of men and women effectively screened for trial enrolment over a period of 10 years. Additionally, data from AddNeuroMed study was used to explore trends in eligibility based on the education criteria. Results Women showed a significantly lower chance of being eligible for screening than men (OR = 1.26; p < 0.01). This imbalance was confirmed by a lower frequency of women screened for enrolment compared to the study population (63.0% vs. 69.5%). Education was revealed as the key criterion contributing to this unbalance, with men showing over twice the chance of being screened compared with women (OR = 2.25, p < 0.01). Education-based differences were greater in earlier born patients, but the gap narrowed and achieved balance with increasing year of birth. This observation was replicated using data from other European populations included in AddNeuroMed study. Comorbidity was the most limiting criterion with sex differences in frequencies and significant discrimination against the selection of men (OR = 0.86, p < 0.01). Conclusions The large number of low-educated elderly women with AD demands for a sex-focused approach in clinical research. New assessment tools insensitive to education level should be developed to enable a proportional representation of women. Although this gender education gap is mostly inexistent in developed countries, economic or cultural factors may lead to different scenarios in other regions. Overlooking the impact of sex may lead to a handicap in AD research with a direct adverse impact on women’s health.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.